Trials
5 active
10 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Obstructive Hypertrophic Cardiomyopathy (2 trials), Heart Failure With Preserved Ejection Fraction, Hypertrophic Cardiomyopathy, Cardiomyopathies
- Main trialPhase 3
- “The study is being conducted to evaluate the efficacy and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy.”In the company’s words, NCT07021976 on ClinicalTrials.gov
Other drugs for Obstructive Hypertrophic Cardiomyopathy
- SotagliflozinLexicon Pharmaceuticals · Phase 3
- BHB-1893Braveheart Bio, Inc. · Phase 3
- AficamtenCytokinetics · Phase 2/3
- BAY3723113Bayer · Phase 3
- NinerafaxstatImbria Pharmaceuticals, Inc. · Phase 2
- QG101-23-0Amckaus PTY LTD. · Phase 2
Coming up2
- Mar 2027Phase 2 trial completes · ClinicalTrials.gov
- Dec 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials10
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | Sep 2026 | A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy | |
| Phase 2Active, not recruiting | 18 Nov 2024 | A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy | |
| Phase 2Recruiting | Mar 2027 | A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction | |
| Phase 2Recruiting | Dec 2027 | A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy | |
| Phase 1Not yet recruiting | Jul 2026 | Human Mass Balance Study of [¹⁴C]HRS-1893 | |
| Phase 2Completed | 18 Nov 2025 | A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy | |
| Phase 1Completed | 21 Mar 2024 | A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy | |
| Phase 1Completed | 20 May 2024 | Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects | |
| Phase 1Completed | 23 Jul 2025 | Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function | |
| Phase 1Completed | 21 Mar 2026 | A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026